Izabella Valdez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Izabella Valdez has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Y. Rudensky
Howard Hughes Medical Institute, Immunology Program, and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, USA
1 shared publication - Beatrice Hoyos
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 1
1 shared publication - Michail Schizas
Immunology Program, Memorial Sloan Kettering Cancer Center 1 , New York, NY
1 shared publication - Paula Gonzalez-Figueroa
Francis Crick Institute, London, UK
1 shared publication - Quan-Zhen Li
Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
1 shared publication - Rahul Sharma
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 1
1 shared publication
Latest Publications
- Open Access
- 7 June 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (7)
CXCR4+ Treg cells control serum IgM levels and natural IgM autoantibody production by B-1 cells in the bone marrow
Regulatory T (Treg) cells represent a specialized lineage of suppressive CD4+ T cells whose functionality is critically dependent on their ability to migrate to and dwell in the proximity of cells they control. Here we show that continuous expression of the chemokine receptor CXCR4 in Treg cells is required for their ability to accumulate in the bone marrow (BM). Induced CXCR4 ablation in Treg cells led to their rapid depletion and consequent increase in mature B cells, foremost the B-1 subset, observed exclusively in the BM without detectable changes in plasma cells or hematopoietic stem cells or any signs of systemic or local immune activation elsewhere. Dysregulation of BM B-1 B cells was associated with a highly specific increase in IgM autoantibodies and total serum IgM levels. Thus, Treg cells control autoreactive B-1 B cells in a CXCR4-dependent manner. These findings have significant implications for understanding the regulation of B cell autoreactivity and malignancies.
- 7 June 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (7)
Open AccessCXCR4+ Treg cells control serum IgM levels and natural IgM autoantibody production by B-1 cells in the bone marrow
Regulatory T (Treg) cells represent a specialized lineage of suppressive CD4+ T cells whose functionality is critically dependent on their ability to migrate to and dwell in the proximity of cells they control. Here we show that continuous expression of the chemokine receptor CXCR4 in Treg cells is required for their ability to accumulate in the bone marrow (BM). Induced CXCR4 ablation in Treg cells led to their rapid depletion and consequent increase in mature B cells, foremost the B-1 subset, observed exclusively in the BM without detectable changes in plasma cells or hematopoietic stem cells or any signs of systemic or local immune activation elsewhere. Dysregulation of BM B-1 B cells was associated with a highly specific increase in IgM autoantibodies and total serum IgM levels. Thus, Treg cells control autoreactive B-1 B cells in a CXCR4-dependent manner. These findings have significant implications for understanding the regulation of B cell autoreactivity and malignancies.